The Medical World Is Still Ignoring Half The Population (And I Have The Receipts To Prove It)

I was sitting in my doctor's waiting room last Tuesday, staring at a poster about heart health that looked like it had been designed in 1984, when I realized something incredibly annoying. (The waiting room smelled like stale peppermint and misplaced hope, which never helps my mood.) Most of what we know about medicine is based on a default human being who looks absolutely nothing like me. Or my sister. Or my neighbor Sarah, who is an architect and once built a scale model of the Eiffel Tower out of linguine just to prove she could. (Sarah is a force of nature, but her inhaler still does not work properly during the third week of her cycle.) I once spent three thousand dollars on a series of diagnostic tests that essentially concluded I was "stressed." (I could have told them that for the price of a mid-range bottle of Chardonnay, but the medical billing department had other plans for my savings.)

It is a biological comedy of errors, although I am certainly not finding the humor in it. For decades, the medical establishment treated the female body as a slightly more complicated, hormonal version of the male body. It was not until the year 1993 that the National Institutes of Health actually mandated that women be included in clinical research. (I was already out of college and nursing my first major heartbreak by then. It took them until 1993. Let that sink in for a moment.) Before that, researchers argued that women were too messy for science. Our hormones fluctuated. Our cycles created too many variables. So, they just left us out. It was easier that way. (Easier for them, anyway. Less so for the rest of us.) That is not some clerical error; it is a systematic erasure of reality.

The Ghost In The Laboratory

Even though the law was updated in 1993 through the NIH Revitalization Act, the lingering shadow of that previous exclusion still haunts our modern laboratories. Scientists may permit women to participate now, but they frequently neglect to analyze the resulting data based on sex or the specific phase of the menstrual cycle. They just lump everyone together and hope for the best. (Hope is a pathetic strategy for high-level clinical trials. I learned that the hard way when I tried to cut my own bangs in 2020.) I assumed we would have advanced beyond this by now, just as I assumed we would all be commuting in flying cars by the year 2000. (We are still stuck in traffic, and women are still stuck with male-standardized medicine.)

The menstrual cycle is not just about reproduction. It is a metabolic engine. These hormonal shifts affect how your liver processes toxins, how your brain signals for sleep, and how your heart responds to stress. When a study omits these factors, it is delivering a version of the truth that is profoundly incomplete. It is like trying to understand the weather by only looking at the sky on Tuesdays. (And only when it is sunny. And only in Phoenix.) We are effectively ignoring the internal climate of four billion people because it is "too complicated" to track. (I manage to track my frequent flyer miles, my monthly subscriptions, and the varying temperaments of my three cats, so surely a PhD-level researcher can manage a calendar.)

The Price Of Being An Afterthought

This is not just a theoretical gripe. There are real, physical consequences to this scientific laziness. According to a report by the Government Accountability Office, eight out of ten drugs withdrawn from the market between 1997 and 2000 posed greater health risks for women than for men. (Eight out of ten. That is not a minor statistical error; that is a systemic failure of imagination.) This is what happens when you treat the female body as an afterthought. We are talking about misdiagnosis. We are talking about side effects that no one warned us about because no one bothered to check. (I am getting a headache just thinking about it, and I am fairly certain the aspirin I took was only tested on college-aged men in 1972.)

Take my friend Sarah again. My friend Sarah, who is a brilliant architect capable of designing a skyscraper with nothing more than a toothpick and her own stubbornness, spent several years attempting to understand why her inhaler failed her for one specific week every month. Her physician dismissed her concerns by suggesting it was merely stress. (The universal medical code for "I do not know and I am not going to check.") It turns out that for many women, asthma symptoms fluctuate wildly with the menstrual cycle due to hormonal impacts on airway inflammation. Estrogen is neuroprotective, but it also behaves as a cardiovascular player. When a psychiatrist or a general practitioner prescribes a medication without considering how those hormones will interact with the drug, they are essentially shooting in the dark. (I do not like it when people guess with my brain chemistry. I barely trust myself to guess the correct amount of pasta for dinner.)

Did You Know?

Women are nearly twice as likely as men to experience adverse drug reactions, according to a 2020 study published in Biology of Sex Differences. This is often because drug dosages are calculated based on male-dominated clinical trials. (Essentially, we are being given the wrong dose because someone decided a 180-pound man was the universal standard.) It is a dangerous game of pharmaceutical roulette where the house always wins, and the house is a windowless lab in New Jersey.

The Cardiovascular Blind Spot

We also have to talk about cardiovascular health, because the ignorance there is legitimately lethal. Heart disease is the leading cause of death for women, yet for years, the "standard" symptoms we were taught - like crushing chest pain - were based primarily on male patients. (I grew up thinking a heart attack looked like a man clutching his left arm and falling over. That is a cinematic trope, not a universal medical reality.) Women often experience different symptoms, such as nausea, fatigue, or jaw pain. Furthermore, the way hormones protect the heart changes as a woman moves through her cycle and into menopause. (I have a friend named Elena who went to the emergency room with jaw pain and was told she needed a better dentist. It was a myocardial infarction. She is fine now, but she has a very low opinion of that hospital's triage desk.)

In the world of high-stakes pharmaceutical research, time is money. Researchers claim that adding female subjects - and specifically accounting for their hormonal phases - makes studies too expensive. But I would argue that the cost of not doing this research is much higher. The cost of hospital readmissions, adverse reactions, and ineffective treatments is a burden on our entire healthcare system. (We are paying the price for this "efficiency" every single day, often with our own lives.) I am tired of hearing that women's bodies are too complex to study. If we can put a rover on Mars, we can certainly figure out how a beta-blocker interacts with progesterone. (It is not rocket science; it is just regular science that people have decided to ignore.)

How To Demand A Better Standard Of Care

So, what are we supposed to do? Should we all just carry around a copy of the 1993 NIH Revitalization Act and slap it onto our doctor's clipboards? (I have considered it, but I am trying to be less confrontational in my middle age.) The first step is simply knowing that this gap exists. Knowledge is a weapon, even if it is a messy one. When you are prescribed a new medication, ask your doctor if it has been specifically studied in women and if the dosage should change based on your cycle. If they look at you like you have sprouted a second head, find a new doctor. I have started doing this myself, and while it leads to some awkward silences, it also leads to better conversations about my health. It is worth the discomfort. (Awkward silences are a small price to pay for not being accidentally poisoned by a dosage designed for a linebacker.)

This is a fancy way of saying that researchers should have to report their results for men and women separately. If a study says a drug is eighty percent effective but does not tell you that it is ninety percent effective for men and only seventy percent for women, that is a problem. Finally, we need to take our own data seriously. Use a tracking app or a paper journal to note how your symptoms and reactions to medication change throughout the month. (I use an app that mostly tells me when I am likely to cry at cat commercials, but it also tracks my migraines.) You are filling in the blanks that the medical industry left behind. It is a small act of rebellion, but it is one that can change the trajectory of your care. It is easy to feel small in the face of a massive medical industrial complex. It is easy to assume that the experts know what they are doing. But as I have learned through years of writing about these failures, the experts are often just people who are following an outdated script. It is time to rewrite the script. It is time to acknowledge that the menstrual cycle is a vital sign, not a variable to be ignored. We deserve medicine that is built for our bodies, not for a simplified version of them.

The Bottom Line

The medical community's long-standing habit of omitting the menstrual cycle from clinical research is not just a historical footnote. It is a current, active threat to the health of women everywhere. We have moved past the era of legally mandated exclusion, but we are still stuck in an era of functional neglect. By failing to account for the biological reality of half the population, we are settling for a version of medicine that is less accurate, less safe, and less effective than it could be. It is a systemic failure that requires a systemic solution, but it also requires individual courage to question the status quo. (And maybe a little bit of righteous indignation.) As you navigate your own health journey, remember that your body's rhythms are not a complication. Do not let any researcher or clinician tell you that your cycle makes the data too messy. The mess is where the truth lives. We need a medical system that is brave enough to embrace that mess and wise enough to use it to save lives. Until then, keep asking questions, keep tracking your data, and keep demanding the care you actually deserve. The days of the invisible patient are over. It is time for medicine to see us as we truly are. I am going to finish my wine now and hope that by the time I have my next check-up, my doctor will be as interested in my hormonal health as I am. (I am not holding my breath, but I am sharpening my questions.)

⏱️ Quick Takeaways

Frequently Asked Questions

❓ What was the 1977 FDA policy that excluded women?

The short answer is that the FDA was trying to prevent birth defects after the thalidomide crisis, so they banned women of "childbearing potential" from early clinical trials. While the intentions were ostensibly good, it meant that for decades, we knew almost nothing about how new drugs worked in the female body. This policy stayed in place until the early 1990s, leaving a legacy of incomplete medical data that we are still dealing with today. (It was a classic case of protecting women by excluding them from the very things that would keep them safe.)

❓ Does my menstrual cycle really change how medicine works?

Here is the thing: your hormones are basically the conductors of your body's internal orchestra. When estrogen and progesterone levels shift, they can change everything from your stomach's acidity to how fast your liver breaks down chemicals. This means a drug might be perfectly effective one week and potentially toxic or completely useless the next. Without cycle-specific research, we are essentially guessing about the correct timing and dosage for millions of women. (And as I have mentioned, I am not a fan of guessing when it comes to my vital organs.)

❓ Why do researchers still call the menstrual cycle "noise"?

The reality is that scientific research is often driven by a desire for the cleanest, most predictable data possible. Because female hormones fluctuate, they introduce variables that can make results harder to interpret or require a larger number of participants to achieve statistical significance. Calling it "noise" is essentially a way for researchers to justify avoiding the extra work and expense that comes with studying a more complex biological system. (It is essentially the scientific equivalent of saying "I do not want to do my homework because it is hard.")

❓ Are there specific drugs that have been dangerous for women?

The list is longer than most people realize, but the most famous example involves a common sleep aid. For years, women were prescribed the same dose as men, only to find that they were metabolizing it much more slowly, leading to a significant increase in morning-after car accidents. Eventually, the FDA had to step in and mandate a fifty percent lower dose for women. This is a clear example of how excluding women from initial dosage trials can have real-world, life-threatening consequences. (It is also a reminder that "one size fits all" usually means "one size fits men.")

❓ How can I tell if a study included women or tracked the menstrual cycle?

This depends on your patience for reading medical journals, but you can usually find this in the "Methods" or "Results" section of a study. Look for phrases like "sex-disaggregated data" or descriptions of how they accounted for hormonal phases. If the study just says "adult participants" without breaking down the results by sex, it is a red flag. You can also use online databases like ClinicalTrials.gov to see the demographics of specific research studies. (It takes some digging, but your health is worth the investigative work.)

Disclaimer: This article is for informational purposes only and does not constitute professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read here.